Search research articles
Contact Us
Filters
Showing results (961-970 of 1,155) with videos related to
Page
of 116
Sort By:
Plos One
|
August 15, 2018
Age- and sex-dependent changes in sympathetic activity of the left ventricular apex assessed by 18F-DOPA PET imaging
Irene A Burger, Christine Lohmann, Michael Messerli, et al.
JAMA Oncology
|
July 17, 2020
Adjuvant Systemic Chemotherapy vs Active Surveillance Following Up-front Resection of Isolated Synchronous Colorectal Peritoneal Metastases
Koen P Rovers, Checca Bakkers, Felice N van Erning, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
October 3, 2021
Metabolic positron emission tomography/CT response after induction chemotherapy and chemo(re)irradiation is associated with higher negative resection margin rate in patients with locally recurrent rectal cancer
Desley M G I van Zoggel, Eva L K Voogt, Ineke G van Lijnschoten, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 18, 2020
Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [<sup>68</sup>Ga]PSMA-PET-guided metastasis-directed therapy
Marco M E Vogel, Stephanie G C Kroeze, Christoph Henkenberens, et al.
Blood
|
July 26, 2019
Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL
Constantine S Tam, Judith Trotman, Stephen Opat, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 29, 2024
Intraperitoneal pharmacokinetics of systemic oxaliplatin, 5-fluorouracil and bevacizumab in patients with colorectal peritoneal metastases
Pascale C S Rietveld, Niels A D Guchelaar, Ruben A G van Eerden, et al.
European Urology Focus
|
September 10, 2019
Prostate-specific Membrane Antigen Positron Emission Tomography-detected Oligorecurrent Prostate Cancer Treated with Metastases-directed Radiotherapy: Role of Addition and Duration of Androgen Deprivation
Stephanie G C Kroeze, Christoph Henkenberens, Nina Sophie Schmidt-Hegemann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 1, 2020
Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy-a multicenter retrospective study
N-S Schmidt-Hegemann, S G C Kroeze, C Henkenberens, et al.
Lancet (London, England)
|
March 22, 2015
Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis
Rodney Dawson, Andreas H Diacon, Daniel Everitt, et al.
Journal of Contemporary Brachytherapy
|
October 6, 2022
Narrowing the difference in dose delivery for IOERT and IOBT for locally advanced and locally recurrent rectal cancer
An-Sofie E Verrijssen, Wim J F Dries, Jeltsje S Cnossen, et al.
Page
of 116
Search research articles
Search
Showing results (961-970 of 1,155) with videos related to
Sort By:
Page
of 116
Plos One
|
August 15, 2018
Age- and sex-dependent changes in sympathetic activity of the left ventricular apex assessed by 18F-DOPA PET imaging
Irene A Burger, Christine Lohmann, Michael Messerli, et al.
JAMA Oncology
|
July 17, 2020
Adjuvant Systemic Chemotherapy vs Active Surveillance Following Up-front Resection of Isolated Synchronous Colorectal Peritoneal Metastases
Koen P Rovers, Checca Bakkers, Felice N van Erning, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
October 3, 2021
Metabolic positron emission tomography/CT response after induction chemotherapy and chemo(re)irradiation is associated with higher negative resection margin rate in patients with locally recurrent rectal cancer
Desley M G I van Zoggel, Eva L K Voogt, Ineke G van Lijnschoten, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 18, 2020
Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [<sup>68</sup>Ga]PSMA-PET-guided metastasis-directed therapy
Marco M E Vogel, Stephanie G C Kroeze, Christoph Henkenberens, et al.
Blood
|
July 26, 2019
Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL
Constantine S Tam, Judith Trotman, Stephen Opat, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
May 29, 2024
Intraperitoneal pharmacokinetics of systemic oxaliplatin, 5-fluorouracil and bevacizumab in patients with colorectal peritoneal metastases
Pascale C S Rietveld, Niels A D Guchelaar, Ruben A G van Eerden, et al.
European Urology Focus
|
September 10, 2019
Prostate-specific Membrane Antigen Positron Emission Tomography-detected Oligorecurrent Prostate Cancer Treated with Metastases-directed Radiotherapy: Role of Addition and Duration of Androgen Deprivation
Stephanie G C Kroeze, Christoph Henkenberens, Nina Sophie Schmidt-Hegemann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 1, 2020
Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy-a multicenter retrospective study
N-S Schmidt-Hegemann, S G C Kroeze, C Henkenberens, et al.
Lancet (London, England)
|
March 22, 2015
Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis
Rodney Dawson, Andreas H Diacon, Daniel Everitt, et al.
Journal of Contemporary Brachytherapy
|
October 6, 2022
Narrowing the difference in dose delivery for IOERT and IOBT for locally advanced and locally recurrent rectal cancer
An-Sofie E Verrijssen, Wim J F Dries, Jeltsje S Cnossen, et al.
Page
of 116